Exploiting Oncogenic Drivers along the CCNG1 Pathway for Cancer Therapy and Gene Therapy

被引：17

作者：

Al-Shihabi, Ahmad ^{[1
]}

Chawla, Sant P. ^{[1
]}

Hall, Frederick L. ^{[2
]}

Gordon, Erlinda M. ^{[1
,2
,3
]}

机构：

[1] Sarcoma Oncol Ctr, Canc Ctr Southern Calif, 2811 Wilshire Blvd,Suite 414, Santa Monica, CA 90403 USA

[2] Delta Next Gene LLC, Santa Monica, CA 90403 USA

[3] Aveni Fdn, Santa Monica, CA 90403 USA

来源：

MOLECULAR THERAPY-ONCOLYTICS | 2018年 / 11卷

关键词：

CYCLIN G1; REXIN-G; C-MYC; P53; TARGET; TUMOR;

D O I：

10.1016/j.omto.2018.11.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：122 / 126

页数：5

共 25 条

[1] Hepatitis B virus X protein mediated suppression of miRNA-122 expression enhances hepatoblastoma cell proliferation through cyclin G1-p53 axis [J].

Bandopadhyay, Manikankana ;

Sarkar, Neelakshi ;

Datta, Sibnarayan ;

Das, Dipanwita ;

Pal, Ananya ;

Panigrahi, Rajesh ;

Banerjee, Arup ;

Panda, Chinmay K. ;

Das, Chandrima ;

Chakrabarti, Shekhar ;

Chakravarty, Runu .

INFECTIOUS AGENTS AND CANCER, 2016, 11

[2]

Bruckner H., 2010, J CLIN ONCOL, V28, P4149

[3]

Chawla S.P., 2016, SARCOMA RES INT, V3, P1

[4] Advanced Phase I/II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Gemcitabine-resistant Metastatic Pancreatic Cancer [J].

Chawla, Sant P. ;

Chua, Victoria S. ;

Fernandez, Lita ;

Quon, Dorris ;

Blackwelder, William C. ;

Gordon, Erlinda M. ;

Hall, Frederick L. .

MOLECULAR THERAPY, 2010, 18 (02) :435-441

[5] Phase I/II and Phase II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Chemotherapy-resistant Sarcoma and Osteosarcoma [J].

Chawla, Sant P. ;

Chua, Victoria S. ;

Fernandez, Lita ;

Quon, Doris ;

Saralou, Andreh ;

Blackwelder, William C. ;

Hall, Frederick L. ;

Gordon, Erlinda M. .

MOLECULAR THERAPY, 2009, 17 (09) :1651-1657

[6] MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells [J].

Fornari, Francesca ;

Gramantieri, Laura ;

Giovannini, Catia ;

Veronese, Angelo ;

Ferracin, Manuela ;

Sabbioni, Silvia ;

Calin, George Adrian ;

Grazi, Gian Luca ;

Croce, Carlo Maria ;

Tavolari, Simona ;

Chieco, Pasquale ;

Negrini, Massimo ;

Bolondi, Luigi .

CANCER RESEARCH, 2009, 69 (14) :5761-5767

[7] Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (rexin-G) in patients with advanced pancreatic cancer [J].

Galanis, Evanthia ;

Carlson, Stephanie K. ;

Foster, Nathan R. ;

Lowe, Val ;

Quevedo, Fernando ;

McWilliams, Robert R. ;

Grothey, Axel ;

Jatoi, Aminah ;

Alberts, Steven R. ;

Rubin, Joseph .

MOLECULAR THERAPY, 2008, 16 (05) :979-984

[8]

Gerber DE, 2008, AM FAM PHYSICIAN, V77, P311

[9] Cell cycle checkpoint control: The cyclin G1/Mdm2/p53 axis emerges as a strategic target for broad-spectrum cancer gene therapy - A review of molecular mechanisms for oncologists [J].

Gordon, Erlinda M. ;

Ravicz, Joshua R. ;

Liu, Seiya ;

Chawla, Sant P. ;

Hall, Frederick L. .

MOLECULAR AND CLINICAL ONCOLOGY, 2018, 9 (02) :115-134

[10] Cyclin g1 is a target of miR-122a, a MicroRNA frequently down-regulated in human hepatocellular carcinoma [J].

Gramantieri, Laura ;

Ferracin, Manuela ;

Fornari, Francesca ;

Veronese, Airtgelo ;

Sabbioni, Silvia ;

Liu, Chang-Gong ;

Calin, George A. ;

Giovannini, Catia ;

Ferrazzi, Eros ;

Grazi, Gian Luca ;

Croce, Carlo M. ;

Bolondi, Luigi ;

Negrini, Massimo .

CANCER RESEARCH, 2007, 67 (13) :6092-6099

← 1 2 3 →